Literature DB >> 7532003

Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide.

R X Xu1, J M Word, D G Davis, M J Rink, D H Willard, R T Gampe.   

Abstract

Human pp60c-src is a cellular nonreceptor tyrosine kinase that participates in cytosolic signal transduction and has been implicated in the development of malignant tumors in the human breast and colon. Signal transduction is mediated by highly specific interactions between the SH2 domain and receptor phosphorylated tyrosine binding motifs. To elucidate the molecular conformation and interactions in solution, a family of highly resolved nuclear magnetic resonance (NMR) structures was determined for the src SH2 domain complexed with a high-affinity phosphorylated pentapeptide, acetyl-p YEEIE-OH. The 23 structures, generated with a distance geometry (DG) and a dynamical simulated annealing (SA) procedure, satisfied 2072 experimental restraints derived from a variety of multifrequency/multidimensional and isotope-filtered NMR data. Superimposition of residues 143-245 upon the mean coordinate set yielded an atomic rmsd of 0.58 +/- 0.09 A for the N, C alpha, C' atoms and 1.04 +/- 0.08 for all the non-hydrogen atoms. Residues in the ordered secondary structure regions superimpose to 0.29 +/- 0.04 A for the N, C alpha, C' and 0.73 +/- 0.08 A for all the non-hydrogen atoms. The angular order parameter calculated for the phi, psi angles was > 0.9 for 81 of the 106 protein residues. The main protein conformational features are three antiparallel beta-strands that traverse a compact core with an alpha-helix on each side of the core near the N- and C-termini. The observed intermolecular nuclear Overhauser effects (NOE) from the pY, +1E, and +3I residues positioned the ligand in an extended conformation across the SH2 domain surface with the pY and +3I side chains inserted into the protein binding pockets. In general, the protein conformation is consistent with previously reported structures of different SH2 domain complexes determined by X-ray crystallography. However, inter- or intramolecular interactions involving the guanidinium side chains of the solvated R alpha A2 or the buried R beta B5 were not observed at pH = 5.5 or 7.0. If such interactions exist in solution, the absence of any confirming data probably arises from rapid exchange with solvent and/or undetermined dynamic components. Thus, the unrestrained R alpha A2 side chain did not show an amino-aromatic interaction or a hydrogen bond to the -1 carbonyl oxygen as observed in the crystal structures. This result is consistent with the solution structure of a different SH2 domain complex. A more detailed comparison between the crystal structure and the NMR-derived solution structures of the same src SH2 domain complex is presented.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7532003     DOI: 10.1021/bi00007a003

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  18 in total

1.  Comparison of binding energies of SrcSH2-phosphotyrosyl peptides with structure-based prediction using surface area based empirical parameterization.

Authors:  D A Henriques; J E Ladbury; R M Jackson
Journal:  Protein Sci       Date:  2000-10       Impact factor: 6.725

2.  Reconstitution of a native-like SH2 domain from disordered peptide fragments examined by multidimensional heteronuclear NMR.

Authors:  D D Ojennus; M R Fleissner; D S Wuttke
Journal:  Protein Sci       Date:  2001-11       Impact factor: 6.725

3.  Electrostatic interactions in the reconstitution of an SH2 domain from constituent peptide fragments.

Authors:  Deanna Dahlke Ojennus; Sarah E Lehto; Deborah S Wuttke
Journal:  Protein Sci       Date:  2003-01       Impact factor: 6.725

4.  Conformationally constrained peptidomimetic inhibitors of signal transducer and activator of transcription. 3: Evaluation and molecular modeling.

Authors:  Pijus K Mandal; Donald Limbrick; David R Coleman; Garrett A Dyer; Zhiyong Ren; J Sanderson Birtwistle; Chiyi Xiong; Xiaomin Chen; James M Briggs; John S McMurray
Journal:  J Med Chem       Date:  2009-04-23       Impact factor: 7.446

5.  Structure of a specific peptide complex of the carboxy-terminal SH2 domain from the p85 alpha subunit of phosphatidylinositol 3-kinase.

Authors:  A L Breeze; B V Kara; D G Barratt; M Anderson; J C Smith; R W Luke; J R Best; S A Cartlidge
Journal:  EMBO J       Date:  1996-07-15       Impact factor: 11.598

6.  Conformation of an Shc-derived phosphotyrosine-containing peptide complexed with the Grb2 SH2 domain.

Authors:  K Ogura; S Tsuchiya; H Terasawa; S Yuzawa; H Hatanaka; V Mandiyan; J Schlessinger; F Inagaki
Journal:  J Biomol NMR       Date:  1997-10       Impact factor: 2.835

7.  Improved convergence of binding affinities with free energy perturbation: application to nonpeptide ligands with pp60src SH2 domain.

Authors:  D J Price; W L Jorgensen
Journal:  J Comput Aided Mol Des       Date:  2001-08       Impact factor: 3.686

8.  pH titration studies of an SH2 domain-phosphopeptide complex: unusual histidine and phosphate pKa values.

Authors:  A U Singer; J D Forman-Kay
Journal:  Protein Sci       Date:  1997-09       Impact factor: 6.725

9.  Solution studies of the SH2 domain from the fyn tyrosine kinase: secondary structure, backbone dynamics and protein association.

Authors:  A Pintar; M Hensmann; K Jumel; M Pitkeathly; S E Harding; I D Campbell
Journal:  Eur Biophys J       Date:  1996       Impact factor: 1.733

10.  Conformational determinants of phosphotyrosine peptides complexed with the Src SH2 domain.

Authors:  Joseph Nachman; Gerry Gish; Cristina Virag; Tony Pawson; Régis Pomès; Emil Pai
Journal:  PLoS One       Date:  2010-06-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.